Article
A study to assess the impact of cobas Liat point-of-care PCR assays (SARS-CoV-2 and Influenza A/B) on patient clinical management in the emergency department of the University of California at Davis Medical Center
2022-08-09
Abstract excerpt
<h4>Background</h4> Rapid detection of SARS-CoV-2 is crucial for reduction of transmission and clinical decision-making. The cobas ® SARS-CoV-2 & Influenza A/B nucleic acid test for use on the cobas Liat ® System is a rapid (20 minutes) point-of-care (POC) polymerase chain reaction (PCR) method. <h4>Methods</h4> This unblinded, pre-post study enrolled consecutive patients with symptoms/signs consistent with SARS-C...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dae5facf-5347-57f3-b8ba-507316a3d1cd
- DOI
- 10.1101/2022.08.08.22278536
